Molecular Dynamics Simulations Reveal the Mechanisms of Allosteric Activation of Hsp90 by Designed Ligands

被引:0
|
作者
Gerolamo Vettoretti
Elisabetta Moroni
Sara Sattin
Jiahui Tao
David A. Agard
Anna Bernardi
Giorgio Colombo
机构
[1] Istituto di Chimica del Riconoscimento Molecolare,Dipartimento di Chimica
[2] CNR (ICRM-CNR),undefined
[3] Università degli Studi di Milano,undefined
[4] Howard Hughes Medical Institute and Dept. of Biochemistry & Biophysics,undefined
[5] University of California,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Controlling biochemical pathways through chemically designed modulators may provide novel opportunities to develop therapeutic drugs and chemical tools. The underlying challenge is to design new molecular entities able to act as allosteric chemical switches that selectively turn on/off functions by modulating the conformational dynamics of their target protein. We examine the origins of the stimulation of ATPase and closure kinetics in the molecular chaperone Hsp90 by allosteric modulators through atomistic molecular dynamics (MD) simulations and analysis of protein-ligand interactions. In particular, we focus on the cross-talk between allosteric ligands and protein conformations and its effect on the dynamic properties of the chaperone’s active state. We examine the impact of different allosteric modulators on the stability, structural and internal dynamics properties of Hsp90 closed state. A critical aspect of this study is the development of a quantitative model that correlates Hsp90 activation to the presence of a certain compound, making use of information on the dynamic adaptation of protein conformations to the presence of the ligand, which allows to capture conformational states relevant in the activation process. We discuss the implications of considering the conformational dialogue between allosteric ligands and protein conformations for the design of new functional modulators.
引用
收藏
相关论文
共 50 条
  • [31] Insight into the structural and dynamic properties of novel HSP90 inhibitors through DFT calculations and molecular dynamics simulations
    Saouli, Ibtissam
    Abrane, Rahma
    Bidjou-Haiour, Chahra
    Boudiba, Sameh
    JOURNAL OF MOLECULAR MODELING, 2024, 30 (12)
  • [32] Molecular Mechanism of Allosteric Communication in Hsp70 Revealed by Molecular Dynamics Simulations
    Chiappori, Federica
    Merelli, Ivan
    Colombo, Giorgio
    Milanesi, Luciano
    Morra, Giulia
    PLOS COMPUTATIONAL BIOLOGY, 2012, 8 (12)
  • [33] Molecular Mechanism of Allosteric Communication in Hsp70 Revealed by Molecular Dynamics Simulations
    Chiappori, Federica
    Merelli, Ivan
    Colombo, Giorgio
    Milanesi, Luciano
    Morra, Giulia
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 571A - 571A
  • [34] Neuroprotective mechanisms activated by HSP90 inhibitors
    Dello Russo, C.
    Feinstein, D. L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 : 16 - 16
  • [35] Molecular insights into the interaction of Hsp90 with allosteric inhibitors targeting the C-terminal domain
    Kumar, Vasantha M. V.
    Noor, Radwan Ebna
    Davis, Rachel E.
    Zhang, Zheng
    Sipavicius, Edvinas
    Keramisanou, Dimitra
    Blagg, Brian S. J.
    Gelis, Ioannis
    MEDCHEMCOMM, 2018, 9 (08) : 1323 - 1331
  • [36] Molecular dynamics studies of Hsp90 with ADP: protein-ligand binding dynamics
    Kawaguchi, Kazutomo
    Takagi, Hiroyuki
    Takasu, Masako
    Saito, Hiroaki
    Nagao, Hidemi
    4TH INTERNATIONAL SYMPOSIUM ON SLOW DYNAMICS IN COMPLEX SYSTEMS: KEEP GOING TOHOKU, 2013, 1518 : 637 - 640
  • [37] Therapeutic and diagnostic implications of Hsp90 activation
    Kamal, A
    Boehm, MF
    Burrows, FJ
    TRENDS IN MOLECULAR MEDICINE, 2004, 10 (06) : 283 - 290
  • [38] Structures of Hsp90α and Hsp90β bound to a purine-scaffold inhibitor reveal an exploitable residue for drug selectivity
    Huck, John D.
    Que, Nanette L. S.
    Sharma, Sahil
    Taldone, Tony
    Chiosis, Gabriela
    Gewirth, Daniel T.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2019, 87 (10) : 869 - 877
  • [39] Hsp90 activation and cell cycle regulation
    Burrows, F
    Zhang, H
    Kamal, A
    CELL CYCLE, 2004, 3 (12) : 1530 - 1536
  • [40] Expressed as the sole Hsp90 of yeast, the α and β isoforms of human Hsp90 differ with regard to their capacities for activation of certain client proteins, whereas only Hsp90β generates sensitivity to the Hsp90 inhibitor radicicol
    Millson, Stefan H.
    Truman, Andrew W.
    Racz, Attila
    Hu, Bin
    Panaretou, Barry
    Nuttall, James
    Mollapour, Mehdi
    Soeti, Csaba
    Piper, Peter W.
    FEBS JOURNAL, 2007, 274 (17) : 4453 - 4463